Programme Parameters
Graduate / Intermediate
3 Days (4.5 Hrs)
Online (e-LMS)
• A basic understanding of the subject area and fundamental programming or scientific concepts.
• A laptop or desktop with a stable internet connection.
• Willingness to complete assignments and the capstone project.
About This Course
The "Cancer Drug Discovery: Creating Cancer Therapies" course offers an in-depth exploration of the mechanisms and methodologies involved in developing new cancer treatments. Participants will delve into the biology of cancer, learning how genetic mutations and cellular pathways contribute to the disease. Every participant receives a verified e-Certificate and e-Marksheet from the Deep Science & Technology Consortium.
🎯 Program Aim
The "Cancer Drug Discovery: Creating Cancer Therapies" course offers an in-depth exploration of the mechanisms and methodologies involved in developing new cancer treatments. Participants will delve into the biology of cancer, learning how genetic mutations and cellular pathways contribute to the disease.
📋 Course Objectives
1. Apply biotechnology methods to authentic research and industry problems.
2. Assemble a documented case study that evidences your applied capability.
👥 Who Should Enroll?
• Master's and senior undergraduate students specializing in biotechnology
• R&D engineers and working professionals applying biotechnology in industry
• Academics and educators building research or teaching capacity in biotechnology
🚀 Key Learning Outcomes
• A demonstrable biotechnology project for your research or industry portfolio.
• A verified e-Certificate of competency and e-Marksheet from the Deep Science & Technology Consortium.
💎 What You'll Gain
Live & Recorded Sessions
Lifetime access to class recordingse-Certificate on Completion
Cryptographically verified credentialPost-Programme Support
Direct access to mentors & councilHands-On Experience
Notebooks, real-world code & datasetsCurriculum Outline
Understanding Cancer and Drug Discovery
Explore cancer biology fundamentals, including key cancer types, stages, and molecular mechanisms of initiation and progression • Analyze cancer diagnosis methods, biomarkers, liquid biopsies, and real-world case studies in early detection • Examine the drug discovery process, the role of medicinal chemists, and targeted therapy drug classes
Target Identification and Lead Optimization
Identify and validate molecular targets and biomarkers using contemporary target validation techniques • Apply high-throughput screening, virtual screening, and medicinal chemistry strategies for lead optimization • Design targeted drugs for specific cancers including breast, lung, and colorectal cancer with tailored strategies
Preclinical Development, Clinical Trials, and Emerging Trends
Evaluate preclinical testing models, clinical trial phases, and regulatory frameworks in drug development • Investigate successful drug design case studies and emerging trends including combination therapies and nanomedicine • Develop personalized medicine approaches, overcome treatment resistance, and explore career paths in oncology pharmacy
Immune System Empowerment and Immunotherapy
Master immune checkpoint inhibitors and CAR-T cell therapy mechanisms for enhancing anti-cancer immune responses • Assess clinical successes, challenges, and ethical considerations in immunotherapy development • Integrate immunotherapy knowledge with traditional drug discovery approaches for comprehensive treatment strategies
Molecular Modeling and Bioinformatics in Drug Design
Utilize structure-based and fragment-based drug design tools for rational drug development • Apply bioinformatics approaches to analyze genomic data and identify novel therapeutic targets • Implement molecular modeling techniques to predict drug-target interactions and optimize compound properties
Pharmacogenomics and Personalized Medicine
Analyze genomic and molecular profiling data to design patient-specific treatment protocols • Apply pharmacogenomic principles to predict drug response and minimize adverse effects • Develop strategies to overcome acquired and intrinsic resistance in cancer therapies
Regulatory Affairs and Clinical Trial Design
Navigate regulatory requirements and compliance standards for oncology drug approval • Design robust clinical trial protocols with appropriate endpoints and patient selection criteria • Evaluate the pharmacy professional's role in clinical trial execution and monitoring
Technical Specifications
| Parameter | Requirement |
|---|---|
| Covered Tool / Platform | AutoDock |
| Covered Tool / Platform | Schrödinger Suite |
| Covered Tool / Platform | NCBI |
| Covered Tool / Platform | PDB |
| Covered Tool / Platform | DrugBank |
| Covered Tool / Platform | Cheminformatics tools |
| Covered Tool / Platform | Genomic analysis platforms |
| Covered Tool / Platform | Clinical trial management systems |
| Covered Tool / Platform | Virtual screening pipelines |
Frequently Asked Questions
Scholar Feedback & Reviews
Based on 0 scholar submissions
Rating Breakdown
No verified reviews published yet. Be the first to share your academic experience.
Leave Scholar Feedback
Your rating will help prospective scholars. Ratings below 3 stars are routed privately to the faculty mentor for immediate response.
